Given that a major aspect of the pathophysiology of T2DM is insulin resistance [6], and that insulin receptors are densely expressed in the brain [7], one possible pathway by which T2DM increases the risk for cognitive impairment may be via insulin resistance in the brain. The gene discussed is INSR; the disease is Insulin resistance.